LISATA THERAPEUTICS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
LISATA THERAPEUTICS, INC. (LSTA) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$16.89 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-12
- LISATA THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$16.89M.
- LISATA THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$19.47M.
- LISATA THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$21.48M.
- LISATA THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$56.17M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$16.89M 10-K · filed 2026-03-12 |
| 2024-12-31 | -$19.47M 10-K · filed 2026-03-12 |
| 2023-12-31 | -$21.48M 10-K · filed 2025-02-27 |
| 2022-12-31 | -$56.17M 10-K · filed 2024-02-29 |
| 2021-12-31 | -$28.97M 10-K · filed 2023-03-30 |
| 2020-12-31 | -$19.01M 10-K · filed 2022-03-22 |
| 2019-12-31 | -$19.35M 10-K · filed 2021-02-25 |
| 2018-12-31 | -$16.17M 10-K · filed 2020-03-05 |
| 2017-12-31 | -$27.70M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |